NEW YORK (GenomeWeb News) – Molecular diagnostic testing firm Response Genetics today reported a 13 percent drop year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2013, the Los Angeles-based company recorded revenues of $4.8 million, down from $5.5 million in Q4 2012. While Response DX test revenues were up 3 percent year over year, pharmaceutical client revenues were down 35 percent year over year, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.